{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:37:19Z","timestamp":1777603039614,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.yexcr.2019.111716","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:45:58Z","timestamp":1573735558000},"page":"111716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin\/NFAT and Smad-7"],"prefix":"10.1016","volume":"386","author":[{"given":"Xuguang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2019.111716_bib1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2019.111716_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.111716_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.113.001879","article-title":"Pathological ventricular remodeling: therapies: part 2 of 2","volume":"128","author":"Xie","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.111716_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2019.111716_bib5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","article-title":"Calcium-calcineurin signaling in the regulation of cardiac hypertrophy","volume":"322","author":"Wilkins","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2019.111716_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/abbs\/gmx129","article-title":"Feedback regulation of TGF-beta signaling","volume":"50","author":"Yan","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2019.111716_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","article-title":"Regulation of TGF-beta signaling by Smad7","volume":"41","author":"Yan","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2019.111716_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cvr\/cvt151","article-title":"Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling","volume":"99","author":"Wei","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2019.111716_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","article-title":"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases","volume":"63","author":"Xu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexcr.2019.111716_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.015","article-title":"Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics","volume":"192","author":"Imig","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2019.111716_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cvr\/cvv018","article-title":"Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II","volume":"105","author":"He","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2019.111716_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acel.12507","article-title":"CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKalpha2 and enhancing nuclear translocation of Akt1","volume":"15","author":"Wang","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.yexcr.2019.111716_bib13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1194\/jlr.M074229","article-title":"CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Galpha12\/13","volume":"58","author":"He","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yexcr.2019.111716_bib14","doi-asserted-by":"crossref","first-page":"H89","DOI":"10.1152\/ajpheart.00040.2017","article-title":"Interaction of 12\/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing","volume":"313","author":"Halade","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.111716_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2019.04.011","article-title":"Lipoxygenase drives Lipidomic and metabolic reprogramming in ischemic heart failure","volume":"96","author":"Halade","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.yexcr.2019.111716_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2018.02.009","article-title":"CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis","volume":"117","author":"Zhou","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yexcr.2019.111716_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073490","article-title":"CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy","volume":"8","author":"Westphal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2019.111716_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.110.167510","article-title":"Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide","volume":"334","author":"Xiao","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexcr.2019.111716_bib19","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2019.111716_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fphys.2018.01333","article-title":"Inhibiting receptor of advanced glycation end products attenuates pressure overload-induced cardiac dysfunction by preventing excessive autophagy","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexcr.2019.111716_bib21","article-title":"20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2019.111716_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejphar.2014.04.012","article-title":"Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3","volume":"735","author":"Zhou","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2019.111716_bib23","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00910.2006","article-title":"Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts","volume":"293","author":"Wang","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.111716_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.111716_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2019.111716_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.88.1.44","article-title":"Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.111716_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2019.111716_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.015","article-title":"Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics","volume":"192","author":"Imig","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2019.111716_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prostaglandins.2006.05.023","article-title":"Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids","volume":"82","author":"Xiao","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.111716_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.113.087122","article-title":"CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure","volume":"85","author":"Wang","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2019.111716_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2012.04.008","article-title":"Role of PI3Kalpha and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection","volume":"53","author":"Batchu","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexcr.2019.111716_bib32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/en.2012-2166","article-title":"Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice","volume":"154","author":"Ma","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2019.111716_bib33","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1038\/s41598-017-07512-1","article-title":"Soluble epoxide hydrolase inhibition protected against angiotensin II-induced adventitial remodeling","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2019.111716_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yexcr.2019.111716_bib35","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2019.111716_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"Takeda","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2019.111716_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J. Biomech."},{"key":"10.1016\/j.yexcr.2019.111716_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","article-title":"Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis","volume":"136","author":"Molkentin","year":"2017","journal-title":"Circulation"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719305956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719305956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:27:06Z","timestamp":1757996826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482719305956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0014482719305956"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.111716","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin\/NFAT and Smad-7","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.111716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111716"}}